05894nam 22007454a 450 991045017650332120200520144314.01-281-12625-X97866111262540-8144-2859-2(CKB)1000000000031430(OCoLC)614665643(CaPaEBR)ebrary10075614(SSID)ssj0000172995(PQKBManifestationID)11168325(PQKBTitleCode)TC0000172995(PQKBWorkID)10163134(PQKB)11149342(MiAaPQ)EBC3001805(Au-PeEL)EBL3001805(CaPaEBR)ebr10075614(CaONFJC)MIL112625(OCoLC)748521033(EXLCZ)99100000000003143020040922d2005 uy 0engurcn|||||||||txtccrHope or hype[electronic resource] the obsession with medical advances and the high cost of false promises /Richard A. Deyo, Donald L. PatrickNew York AMACOM, American Management Associationc20051 online resource (352 p.) Bibliographic Level Mode of Issuance: Monograph0-8144-0845-1 Includes bibliographical references (p. [291]-326) and index.Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.Medical innovationsUnited StatesEvaluationMedical technologyUnited StatesEvaluationMedical careTechnological innovationsUnited StatesEvaluationMedical careUnited StatesEvaluationMedical innovationsEconomic aspectsUnited StatesMedical technologyUnited StatesCost effectivenessMedical careTechnological innovationsUnited StatesCost effectivenessMedical care, Cost ofUnited StatesElectronic books.Medical innovationsEvaluation.Medical technologyEvaluation.Medical careTechnological innovationsEvaluation.Medical careEvaluation.Medical innovationsEconomic aspectsMedical technologyCost effectiveness.Medical careTechnological innovationsCost effectiveness.Medical care, Cost of610/.28Deyo Richard A896061Patrick Donald L896062MiAaPQMiAaPQMiAaPQBOOK9910450176503321Hope or hype2001740UNINA